Gene Page: ADAMTS1
Summary ?
GeneID | 9510 |
Symbol | ADAMTS1 |
Synonyms | C3-C5|METH1 |
Description | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
Reference | MIM:605174|HGNC:HGNC:217|Ensembl:ENSG00000154734|HPRD:05530|Vega:OTTHUMG00000078688 |
Gene type | protein-coding |
Map location | 21q21.2 |
Pascal p-value | 0.723 |
TADA p-value | 0.018 |
Fetal beta | -2.47 |
DMG | 1 (# studies) |
eGene | Myers' cis & trans |
Support | CompositeSet Ascano FMRP targets |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Wockner_2014 | Genome-wide DNA methylation analysis | This dataset includes 4641 differentially methylated probes corresponding to 2929 unique genes between schizophrenia patients (n=24) and controls (n=24). | 1 |
DNM:Fromer_2014 | Whole Exome Sequencing analysis | This study reported a WES study of 623 schizophrenia trios, reporting DNMs using genomic DNA. |
Section I. Genetics and epigenetics annotation
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
ADAMTS1 | chr21 | 28214245 | G | A | NM_006988 | p.381P>L | missense | Schizophrenia | DNM:Fromer_2014 |
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg01444578 | 21 | 28216559 | ADAMTS1 | 2.43E-5 | -0.422 | 0.017 | DMG:Wockner_2014 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs798015 | chr1 | 117320906 | ADAMTS1 | 9510 | 0.06 | trans | ||
rs3769467 | chr2 | 201205340 | ADAMTS1 | 9510 | 0.03 | trans | ||
rs3769461 | chr2 | 201222657 | ADAMTS1 | 9510 | 0.03 | trans | ||
rs17204557 | chr3 | 151166057 | ADAMTS1 | 9510 | 0.04 | trans | ||
rs4256179 | chr3 | 169628328 | ADAMTS1 | 9510 | 0.05 | trans | ||
rs9870311 | chr3 | 169641061 | ADAMTS1 | 9510 | 0.05 | trans | ||
rs16891338 | chr8 | 119671196 | ADAMTS1 | 9510 | 0.18 | trans | ||
rs1873825 | chr9 | 72591054 | ADAMTS1 | 9510 | 0.08 | trans | ||
rs12685939 | chr9 | 72684033 | ADAMTS1 | 9510 | 0.04 | trans | ||
rs2275750 | chr10 | 26800505 | ADAMTS1 | 9510 | 0.15 | trans | ||
rs763641 | chr11 | 123846625 | ADAMTS1 | 9510 | 0.04 | trans | ||
rs7107326 | chr11 | 131332566 | ADAMTS1 | 9510 | 0.12 | trans | ||
rs2408301 | chr13 | 51808915 | ADAMTS1 | 9510 | 0 | trans | ||
rs16995131 | chr20 | 48844881 | ADAMTS1 | 9510 | 0.05 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
ABCD4 | 0.86 | 0.82 |
AL161668.2 | 0.86 | 0.83 |
DHTKD1 | 0.86 | 0.85 |
AKT2 | 0.84 | 0.79 |
TULP3 | 0.84 | 0.84 |
TTC31 | 0.84 | 0.78 |
ARHGAP17 | 0.83 | 0.80 |
DDR1 | 0.83 | 0.82 |
ERBB2 | 0.82 | 0.78 |
FANCA | 0.82 | 0.70 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
PLA2G4A | -0.48 | -0.52 |
SERPINI1 | -0.47 | -0.44 |
CHN1 | -0.47 | -0.45 |
C5orf53 | -0.47 | -0.48 |
CCDC85B | -0.46 | -0.57 |
CACNA1F | -0.46 | -0.50 |
ARHGDIG | -0.46 | -0.55 |
RGS4 | -0.46 | -0.50 |
TUBA1 | -0.45 | -0.53 |
AF347015.27 | -0.45 | -0.50 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP | 285 | 181 | All SZGR 2.0 genes in this pathway |
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP | 205 | 140 | All SZGR 2.0 genes in this pathway |
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP | 255 | 177 | All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP | 408 | 247 | All SZGR 2.0 genes in this pathway |
NEWMAN ERCC6 TARGETS DN | 39 | 24 | All SZGR 2.0 genes in this pathway |
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY UP | 18 | 10 | All SZGR 2.0 genes in this pathway |
DITTMER PTHLH TARGETS DN | 73 | 51 | All SZGR 2.0 genes in this pathway |
UDAYAKUMAR MED1 TARGETS DN | 240 | 171 | All SZGR 2.0 genes in this pathway |
ODONNELL TFRC TARGETS UP | 456 | 228 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE EPIDERMIS DN | 508 | 354 | All SZGR 2.0 genes in this pathway |
BEGUM TARGETS OF PAX3 FOXO1 FUSION UP | 60 | 45 | All SZGR 2.0 genes in this pathway |
SASAI RESISTANCE TO NEOPLASTIC TRANSFROMATION | 50 | 31 | All SZGR 2.0 genes in this pathway |
FALVELLA SMOKERS WITH LUNG CANCER | 80 | 52 | All SZGR 2.0 genes in this pathway |
GROSS ELK3 TARGETS DN | 32 | 17 | All SZGR 2.0 genes in this pathway |
WU CELL MIGRATION | 184 | 114 | All SZGR 2.0 genes in this pathway |
BENPORATH CYCLING GENES | 648 | 385 | All SZGR 2.0 genes in this pathway |
ZHANG RESPONSE TO IKK INHIBITOR AND TNF DN | 103 | 64 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 1 DN | 169 | 102 | All SZGR 2.0 genes in this pathway |
NELSON RESPONSE TO ANDROGEN UP | 86 | 61 | All SZGR 2.0 genes in this pathway |
ZHENG RESPONSE TO ARSENITE DN | 18 | 15 | All SZGR 2.0 genes in this pathway |
WANG SMARCE1 TARGETS DN | 371 | 218 | All SZGR 2.0 genes in this pathway |
LINDVALL IMMORTALIZED BY TERT UP | 78 | 48 | All SZGR 2.0 genes in this pathway |
DOUGLAS BMI1 TARGETS UP | 566 | 371 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE BY 4NQO | 38 | 24 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE DN | 195 | 135 | All SZGR 2.0 genes in this pathway |
WALLACE PROSTATE CANCER RACE UP | 299 | 167 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER LUMINAL B DN | 564 | 326 | All SZGR 2.0 genes in this pathway |
LE SKI TARGETS UP | 17 | 12 | All SZGR 2.0 genes in this pathway |
MATZUK PREOVULATORY FOLLICLE | 10 | 8 | All SZGR 2.0 genes in this pathway |
GRADE COLON CANCER DN | 33 | 22 | All SZGR 2.0 genes in this pathway |
CHANG CORE SERUM RESPONSE UP | 212 | 128 | All SZGR 2.0 genes in this pathway |
CHANG CYCLING GENES | 148 | 83 | All SZGR 2.0 genes in this pathway |
HAN SATB1 TARGETS UP | 395 | 249 | All SZGR 2.0 genes in this pathway |
COLINA TARGETS OF 4EBP1 AND 4EBP2 | 356 | 214 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN | 170 | 105 | All SZGR 2.0 genes in this pathway |
GYORFFY DOXORUBICIN RESISTANCE | 56 | 34 | All SZGR 2.0 genes in this pathway |
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN | 37 | 26 | All SZGR 2.0 genes in this pathway |
WONG ADULT TISSUE STEM MODULE | 721 | 492 | All SZGR 2.0 genes in this pathway |
WHITFIELD CELL CYCLE G1 S | 147 | 76 | All SZGR 2.0 genes in this pathway |
LU EZH2 TARGETS DN | 414 | 237 | All SZGR 2.0 genes in this pathway |
HOELZEL NF1 TARGETS DN | 115 | 73 | All SZGR 2.0 genes in this pathway |
PURBEY TARGETS OF CTBP1 NOT SATB1 DN | 448 | 282 | All SZGR 2.0 genes in this pathway |
PLASARI TGFB1 TARGETS 10HR DN | 244 | 157 | All SZGR 2.0 genes in this pathway |
FORTSCHEGGER PHF8 TARGETS UP | 279 | 155 | All SZGR 2.0 genes in this pathway |
LIM MAMMARY STEM CELL UP | 489 | 314 | All SZGR 2.0 genes in this pathway |
ZWANG CLASS 1 TRANSIENTLY INDUCED BY EGF | 516 | 308 | All SZGR 2.0 genes in this pathway |
NABA ECM REGULATORS | 238 | 125 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME ASSOCIATED | 753 | 411 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME | 1028 | 559 | All SZGR 2.0 genes in this pathway |